Frontier Science & Technology Research Foundation, Inc.
Foundation
Location:
Amherst, NY,
United States (USA) (US)
ROR: https://ror.org/04hbhf775
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025)
Conforti F, Holtschmidt J, Nekljudova V, Sala I, Pagan E, Solbach C, Untch M, et al.
Journal article
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer (2025)
Conforti F, Nekljudova V, Sala I, Ascari R, Solbach C, Untch M, Denkert C, et al.
Journal article
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana. (2023)
Shapiro RL, Ajibola G, Maswabi K, Hughes M, Nelson BS, Niesar A, Holme MP, et al.
Journal article